Clinical Trials
4
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Safety and Efficacy of ALC in Breast Cancer in Subjects With Fatigue
- Conditions
- Breast Cancer
- Interventions
- Drug: ALC and Placebo
- First Posted Date
- 2007-11-09
- Last Posted Date
- 2012-08-28
- Lead Sponsor
- Sigma-Tau Research, Inc.
- Target Recruit Count
- 27
- Registration Number
- NCT00555841
- Locations
- 🇺🇸
The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Safety and Efficacy of Propionyl-L-Carnitine in the Treatment of Peripheral Arterial Disease (Intermittent Claudication)
- Conditions
- Peripheral Vascular DiseasesIntermittent Claudication
- Interventions
- Drug: PLC
- First Posted Date
- 2006-11-15
- Last Posted Date
- 2011-08-25
- Lead Sponsor
- Sigma-Tau Research, Inc.
- Target Recruit Count
- 69
- Registration Number
- NCT00399919
- Locations
- 🇺🇸
Jacksonville Center for Clinical Research, Jacksonville, Florida, United States
🇺🇸Baptist Clinical Research, Pensacola, Florida, United States
🇺🇸Western Suburban Cardiologists, Ltd., LaGrange, Illinois, United States
This is an Early Study to Investigate the Effect of Gimatecan® in Adults With Solid Tumor
- Conditions
- Solid Malignancies
- First Posted Date
- 2002-04-10
- Last Posted Date
- 2009-06-03
- Lead Sponsor
- Sigma-Tau Research, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT00033202
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸Rhode Island Hospital, Providence, Rhode Island, United States
This is an Early Study to Investigate the Effect of Gimatecan® in Adults With Malignant Glioma.
- Conditions
- Malignant Glioma
- First Posted Date
- 2002-04-08
- Last Posted Date
- 2009-06-03
- Lead Sponsor
- Sigma-Tau Research, Inc.
- Target Recruit Count
- 59
- Registration Number
- NCT00032903
- Locations
- 🇺🇸
Rhode Island Hospital, Providence, Rhode Island, United States